Clinical Trial Update: Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study [Phase 1, Phase 2]

View source ↗

Summary

A pilot Phase 1/2 clinical trial from Imperial College London evaluates psilocybin as a treatment for anorexia nervosa. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anorexia Nervosa

Drugs mentioned

• Psilocybin (psilocybin)

Snippet

Sponsor: Imperial College London | Conditions: Anorexia Nervosa | Phase 1, Phase 2 | Status: COMPLETED